A concise, scalable synthesis of(-)-galanthamine, a drug being used fo
r the treatment of Alzheimer's disease, is described. The yield of the
critical phenolic coupling step was optimized to 45-50%. For the redu
ction of the aryl bromide, air-activated LiAlH4 was used and racemic n
arwedine was converted to (-)-narwedine by a second order asymmetric t
ransformation. (C) 1998 Elsevier Science Ltd. All rights reserved.